Mr. Parranto was appointed CEO, while Mr. Holder was elected chair of the board of directors, according to a Dec. 5 press release.
Mr. Holder joined the board in January, bringing orthopedic startup and strategic sales experience. He has been serving as acting CEO since April.
He will continue to guide Endeavor’s strategic mission to advance innovation for the repair of periarticular fractures with the company’s orthopedic trauma platform.
Mr. Parranto will take over as the new CEO, bringing an extensive career in orthopedics, particularly as a leader and team builder at Depuy Synthes/Johnson & Johnson family.
He has 16 years of experience in orthopedics with a successful background in sales, marketing and product development.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
